The receptor for complement anaphylatoxin C3a is expressed by myeloid cells and nonmyeloid cells in inflamed human central nervous system: analysis in multiple sclerosis and bacterial meningitis.
The complement anaphylatoxins C5a and C3a are released at the inflammatory site, where they contribute to the recruitment and activation of leukocytes and the activation of resident cells. The distribution of the receptor for C5a (C5aR) has been well studied; however, the receptor for C3a (C3aR) has only recently been cloned, and its distribution is uncharacterized. Using a specific affinity-purified anti-C3aR peptide Ab and oligonucleotides for reverse transcriptase-PCR analysis, C3aR expression was characterized in vitro on myeloid and nonmyeloid cells and in vivo in the brain. C3aR was expressed by adult astrocytes, astrocyte cell lines, monocyte lines THP1 and U937, neutrophils, and monocytes, but not by K562 or Ramos. C3aR staining was confirmed by flow cytometry, confocal imaging, and electron microscopy analysis. A 65-kDa protein was immunoprecipitated by the anti-C3aR from astrocyte and monocyte cell lysates. Our results at the protein level were confirmed at the mRNA level. Using reverse transcriptase-PCR, Southern blot, and sequencing we found that C3aR mRNA was expressed by fetal astrocytes, astrocyte cell lines, and THP1, but not by K562 or Ramos. The astrocyte C3aR cDNA was identical with the reported C3aR cDNA. C3aR expression was not detected in normal brain sections. However, a strong C3aR staining was evident in areas of inflammation in multiple sclerosis and bacterial meningitis. In meningitis, C3aR was abundantly expressed by reactive astrocytes, microglia, and infiltrating cells (macrophages and neutrophils). In multiple sclerosis, infiltrating lymphocytes did not express C3aR, but a strong staining was detected on smooth muscle cells (pericytes) surrounding blood vessels.
Gasque
P
P
Department of Medical Biochemistry, University of Wales College of Medicine, Cardiff, United Kingdom. WMBPG@cardiff.ac.uk
Singhrao
S K
SK
Neal
J W
JW
Wang
P
P
Sayah
S
S
Fontaine
M
M
Morgan
B P
BP
D000328:Adult; D000595:Amino Acid Sequence; D000918:Antibody Specificity; D001253:Astrocytes / Q000378:metabolism; D001921:Brain / Q000276:immunology / Q000378:metabolism / Q000473:pathology*; D002454:Cell Differentiation; D002460:Cell Line; D002462:Cell Membrane / Q000378:metabolism; D015926:Complement C3a / Q000378:metabolism*; D005333:Fetus; D006801:Humans; D007106:Immune Sera / Q000096:biosynthesis; D016177:Macrophage-1 Antigen / Q000096:biosynthesis* / Q000235:genetics / Q000276:immunology; D016920:Meningitis, Bacterial / Q000276:immunology* / Q000473:pathology; D008969:Molecular Sequence Data; D008970:Molecular Weight; D009000:Monocytes / Q000378:metabolism; D009103:Multiple Sclerosis / Q000276:immunology* / Q000473:pathology; D009504:Neutrophils / Q000378:metabolism; D012333:RNA, Messenger / Q000096:biosynthesis; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D014407:Tumor Cells, Cultured
D007106:Immune Sera; D016177:Macrophage-1 Antigen; D012333:RNA, Messenger; D015926:Complement C3a; D013755:Tetradecanoylphorbol Acetate